p-ANCA and ASCA antibodies and the differential diagnosis between ulcerative colitis and Crohn's disease;Gli anticorpi p-ANCA ed ASCA nella diagnosi differenziale fra rettocolite ulcerosa e malattia di Crohn

Recenti Progressi in Medicina

Volumn 93, Issue 5, 2002, Pages 308-313

  Lecis, Pierenrico ^a   Germanà, Bastianello ^a   Papa, Nunziato ^a   Bertiato, Gianni ^a   Doglioni, Claudio ^a   Galliani, Ermenegildo ^a   Biedo, Franco Costan ^a  

^a SAN MARTINO HOSPITAL   (Italy)

Author keywords

ASCA; Crohn's disease; p ANCA; Serological markers; Ulcerative colitis

Indexed keywords

FUNGUS ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; SACCHAROMYCES CEREVISIAE PROTEIN;

ADULT; AGED; ARTICLE; BLOOD; CROHN DISEASE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; ULCERATIVE COLITIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, FUNGAL; COLITIS, ULCERATIVE; CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; SACCHAROMYCES CEREVISIAE PROTEINS;

EID: 0036582020     PISSN: 00341193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. rd ed NewYork: Churchill Livingstone 1997: 343-7.
2. Papadakis KA, Targan SR. Serologic testing in inflammatory bowel disease: its value in indeterminate colitis. Curr Gastroenterol Rep 1999; 1: 482-5.
3. Oudkerk Pool M, et al. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment. Gut 1993; 34: 46-50.
4. Gross WL, Chmitt WH, Csernok E. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin Exp Immunol 1993; 91: 1-12.
5. Giaffer MH, Clark A, Holdsworth CD. Antibodies to Sacchromyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance. Gut 1992; 33: 1071-5.
6. Sutton CL, Yang H, Li Z, Rotter JI, Targan SR, Braun J. Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease. Gut 2000; 46: 58-63.
7. Seibold F, Stich O, Hufnagl R, Kamil S, Scheurlen M. Anti-Saccharomyces cerevisiae antibodies in inflammatory bowel disease: a family study. Scand J Gastroenterol 2001; 36: 196-201.
8. Targan SR. The utility of ANCA ed ASCA in inflammatory bowel disease. Inflamm Bowel Dis 1999; 5: 61-3.
9. Lennard Jones JE. Classification of inflammatory bowel disease. Scand J Gastoenterol (suppl) 1989; 170: 2-6.
10. Wiik A. Delineation of a standard procedure for immunofluorescence detection of ANCA. APMIS 1989; 97: 12-3.
11. Burlina A. Medicina di laboratorio: fondamenti di diagnostica. Torino: Edizioni Medico Scientifiche 1992: 420-37.
12. Nielsen OH, Vainer B, Madsen SM, Seidelin JB, Heegard NH. Established and emerging biological activity markers of inflammatory bowel disease. Am J Gastroenterol 2000; 95: 359-67.
13. Quinton JF, Sendid B, Reumax D, Duthilleul P, Cortot A, Grandbastien B et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1998; 42: 788-91.
14. Peeters M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol 2001; 96: 730-4.
15. Reumaux D, Colombel JF, Masy E, Duclos B, Heresbach D, Belaiche J, Cortot A, Duthilleul P and the GETAID. Anti-neutrophil cytoplasmic auto-antibodies (ANCA) in ulcerative colitis (UC): no relatioship with disease activity. Inflamm Bowel Dis 2000; 6: 270-4.
16. Vecchi M, Gionchetti P et al. P-ANCA and development of pouchitis in ulcerative colitis patients after proctocolectomy and ileoanal pouch anastomosis. Lancet 1994; 344: 886-7.
17. Vasiliauskas EA, Kam LY, Karp LC, Gaiennie J, Yang H, Targan SR. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut 2000; 47: 487-96.
18. Freeman H, Roeck B, Devine D, Carter C. Prospective evaluation of neutrophil autoantibodies in 500 consecutive patients with inflammatory bowel disease. Can J Gastroenterol 1997; 11: 203-7.
19. Ruemmele FM, Targan SR, Levy G, Dubinsky M, Braun J, Seidman EG. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology 1998; 115: 822-9.
20. Vermeire S, Joossens S, Peeters M, Monsuur F, Marien G, Bossuyt X, Groenen P, Vlietinck R, Rutgeerts P. Comparative study of ASCA (anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease. Gastroenterology 2001; 120: 827-33.
21. Hoffenberg EJ, Fidanza S, Sauaia A. Serologic testing for inflammatory bowel disease. J Pediatr 1999; 134: 447-52.